RAF-MEK-ERK pathway in cancer evolution and treatment

Cites (506)

Items 201–400 of 489

1. Characterization of insulin-stimulated microtubule-associated protein kinase. Rapid isolation and stabilization of a novel serine/threonine kinase from 3T3-L1 cells.
   L. Bryan Ray, Thomas Wayne Sturgill · 1988 · Journal of Biological Chemistry
2. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal
   Jian Li, Guangwen Wang, Chengyan Wang, Yang Zhao, Hong Zhang, Zhijia Tan, Zhihua Song, Mingxiao Ding, Hongkui Deng · 2007 · Differentiation
3. A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
   A. Chaikuad, Eliana MC Tacconi, Jutta Zimmer, Yanke Liang, Nathanael S. Gray, Madalena Tarsounas, Stefan Knapp · 2014 · Nature Chemical Biology
4. Regulation of Primary Response Genes
   Trent Fowler, Ranjan Sen, Ananda L. Roy · 2011 · Molecular Cell
5. Targeting Oncogenic BRAF: Past, Present, and Future
   Aubhishek Zaman, Wei Wu, Trever Grant Bivona · 2019 · Cancers
6. An Immediate Response of Ribosomal Transcription to Growth Factor Stimulation in Mammals Is Mediated by ERK Phosphorylation of UBF
   Victor Y. Stefanovsky, Guillaume Pelletier, Ross D. Hannan, Thérèse Gagnon-Kugler, Lawrence Ian Rothblum, Tom Moss · 2001 · Molecular Cell
7. Paxillin Serves as an ERK-Regulated Scaffold for Coordinating FAK and Rac Activation in Epithelial Morphogenesis
   Shuta Ishibe, Dominique Joly, Zhenxiang Liu, Lloyd G. Cantley · 2004 · Molecular Cell
8. Impact of Feedback Phosphorylation and Raf Heterodimerization on Normal and Mutant B-Raf Signaling
   Daniel A. Ritt, Daniel M. Monson, Suzanne I. Specht, Deborah K. Morrison · 2009 · Molecular and Cellular Biology
9. Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment
   Margaret K. Callahan, Raajit K. Rampal, James J. Harding, Virginia M. Klimek, Young Rock Chung, Taha Merghoub, Jedd D. Wolchok, David B. Solit, Neal X. Rosen, Omar Ibrahim Abdel-Wahab et al. · 2012 · New England Journal of Medicine
10. KSR: a MAPK scaffold of the Ras pathway?
    Deborah K. Morrison · 2001 · Journal of Cell Science
11. Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.
    Konstantin I. Galaktionov, Catherine Jessus, David Beach · 1995 · Genes & Development
12. Regulation of carbamoyl phosphate synthetase by MAP kinase
    Lee M. Graves, Hedeel I. Guy, Piotr Kozlowski, Min Huang, Eduardo Rodolfo Lazarowski, R. Marshall Pope, Matthew A. Collins, Erik N. Dahlstrand, Henry Shelton Earp, David R. Evans · 2000 · Nature
13. Identification and Functional Characterization of ERK/MAPK Phosphorylation Sites in the Runx2 Transcription Factor
    Chunxi Ge, Guozhi Xiao, Di Jiang, Qian Yang, Nan E. Hatch, Hernan Roca, Renny T. Franceschi · 2009 · Journal of Biological Chemistry
14. Identification of a selective ERK inhibitor and structural determination of the inhibitor–ERK2 complex
    Makoto Ohori, Takayoshi Kinoshita, Mitsuru Okubo, Kentaro Sato, Akiko Yamazaki, Hiroyuki Arakawa, Shintaro Nishimura, Noriaki Inamura, Hidenori Nakajima, Masahiro Neya et al. · 2005 · Biochemical and Biophysical Research Communications
15. Multisite Phosphorylation Regulates Bim Stability and Apoptotic Activity
    Hübner, Anette, Barrett, Tamera, Flavell, Richard A., Davis, Roger J. · 2008 · Molecular Cell
16. Growth factors can activate ATF2 via a two‐step mechanism: phosphorylation of Thr71 through the Ras–MEK–ERK pathway and of Thr69 through RalGDS–Src–p38
    D. Margriet Ouwens, Nancy D. de Ruiter, Gerard C.M. van der Zon, Andrew P. Carter, Jan Schouten, Corina van der Burgt, Klaas Kooistra, Johannes L. Bos, J. Antonie Maassen, Hans van Dam · 2002 · The EMBO Journal
17. Bidirectional signals transduced by DAPK–ERK interaction promote the apoptotic effect of DAPK
    Chun-Hau Chen, Won‐Jing Wang, Jean‐Cheng Kuo, Hsiao-Chien Tsai, Jia‐Ren Lin, Zee-Fen Chang, Ruey‐Hwa Chen · 2004 · The EMBO Journal
18. Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
    Dietmar Abraham, Klaus Podar, Margit Pacher, Markus Kubicek, Natascha Welzel, Brian A. Hemmings, Stephen M. Dilworth, Harald Mischak, Walter Kölch, Manuela Baccarini · 2000 · Journal of Biological Chemistry
19. Dysregulation of the basal RNA polymerase transcription apparatus in cancer
    Megan J. Bywater, Richard B. Pearson, Grant A. McArthur, Ross D. Hannan · 2013 · Nature reviews. Cancer
20. Active MAP Kinase in Mitosis: Localization at Kinetochores and Association with the Motor Protein CENP-E
    Maja Zečević, Andrew D. Catling, Scott T. Eblen, Luigina Renzi, James C. Hittle, Tim J. Yen, Gary J. Gorbsky, Michael J. Weber · 1998 · The Journal of Cell Biology
21. The Influence of the MAPK Pathway on T Cell Lineage Commitment
    Leslie L. Sharp, David A. Schwarz, Cynthia M. Bott, Christopher J. Marshall, Stephen Μ. Hedrick · 1997 · Immunity
22. CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations
    Keiran S.M. Smalley, Min Xiao, Jessie Villanueva, Thiennga K. Nguyen, Keith T. Flaherty, Richard Letrero, Patricia A. Van Belle, David E. Elder, Yaohong Wang, Katherine L. Nathanson et al. · 2008 · Oncogene
23. KSR is a scaffold required for activation of the ERK/MAPK module
    Roy, François, Laberge, Gino, Douziech, Mélanie, Ferland-McCollough, David, Therrien, Marc · 2002 · Genes & Development
24. Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
    Girotti, Maria Romina, Lopes, Filipa, Preece, Natasha, Niculescu-Duvaz, Dan, Zambon, Alfonso, Davies, Lawrence, Whittaker, Steven, Saturno, Grazia, Viros, Amaya, Pedersen, Malin et al. · 2015 · Cancer Cell
25. Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization
    Naoya Fujita, Saori Sato, Takashi Tsuruo · 2003 · Journal of Biological Chemistry
26. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669
    Ingrid C. Northwood, F.A. Gonzalez, Markus Wartmann, David L. Raden, Roger J. Davis · 1991 · Journal of Biological Chemistry
27. Identification of Constitutive and Ras-Inducible Phosphorylation Sites of KSR: Implications for 14-3-3 Binding, Mitogen-Activated Protein Kinase Binding, and KSR Overexpression
    Angela M. Cacace, Neil R. Michaud, Marc Therrien, Karen D. Mathes, Terry Copeland, Gerald M. Rubin, Deborah K. Morrison · 1999 · Molecular and Cellular Biology
28. Kinase Suppressor of Ras Forms a Multiprotein Signaling Complex and Modulates MEK Localization
    Scott Stewart, Meera V. Sundaram, Yanping Zhang, Jeeyong Lee, Min Han, Kun‐Liang Guan · 1999 · Molecular and Cellular Biology
29. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation
    Masakatsu Yamashita, Motoko Yagi Kimura, Masato Kubo, Chiori Shimizu, Tomio Tada, Roger M. Perlmutter, Toshinori Nakayama · 1999 · Proceedings of the National Academy of Sciences
30. The Serine/Threonine Protein Kinase, p90 Ribosomal S6 Kinase, Is an Important Regulator of Prostate Cancer Cell Proliferation
    D.E. Clark, Timothy M. Errington, Jeffrey A. Smith, Henry F. Frierson, Michael J. Weber, Deborah Ann Lannigan · 2005 · Cancer Research
31. Sp1 Phosphorylation by Erk 2 Stimulates DNA Binding
    Juanita L. Merchant, Ming Du, Andrea Todisco · 1999 · Biochemical and Biophysical Research Communications
32. MAD1 and c‐MYC regulate UBF and rDNA transcription during granulocyte differentiation
    G. Poortinga, K. Hannan, Hayley. Snelling, Carl R Walkley, Anna Jenkins, K. Sharkey, M. Wall, Y. Brandenburger, M. Palatsides, R. Pearson et al. · 2004 · EMBO Journal
33. Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK
    Wei Yu, Wendy J. Fantl, Greg Harrowe, Lewis T. Williams · 1998 · Current Biology
34. Notch‐induced E2A ubiquitination and degradation are controlled by MAP kinase activities
    Lei Nie, Min Xu, Antoaneta Vladimirova, Xiao‐Hong Sun · 2003 · The EMBO Journal
35. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions
    Montserrat Jaumot, John F. Hancock · 2001 · Oncogene
36. The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival
    Warren N. D’Souza, Chiung‐Fang Chang, April M. Fischer, Manqing Li, Stephen Μ. Hedrick · 2008 · The Journal of Immunology
37. The identification of potent and selective imidazole-based inhibitors of B-Raf kinase
    Andrew K. Takle, Murray J. B. Brown, Susannah Davies, David K. Dean, Gerraint Francis, Alessandra Gaiba, Alex Hird, Frank D. King, Peter J. Lovell, A. Naylor et al. · 2005 · Bioorganic & Medicinal Chemistry Letters
38. RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
    Yao, Zhan, Gao, Yijun, Su, Wenjing, Yaeger, Rona, Tao, Jessica, Na, Na, Zhang, Ying, Zhang, Chao, Rymar, Andrey, Tao, Anthony et al. · 2019 · Nature Medicine
39. ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry
    Francisco H. Cruzalegui, Eva Cano, Richard Treisman · 1999 · Oncogene
40. Comprehensive Genomic Profiling of Pancreatic Acinar Cell Carcinomas Identifies Recurrent RAF Fusions and Frequent Inactivation of DNA Repair Genes
    Juliann Chmielecki, Katherine E. Hutchinson, Garrett Michael Frampton, Zachary Rockow Chalmers, Adrienne Johnson, Chanjuan Shi, Julia Andrea Elvin, Siraj Mahamed Ali, Jeffrey S. Ross, Olca Baştürk et al. · 2014 · Cancer Discovery
41. Feedback Inhibition of G Protein-coupled Receptor Kinase 2 (GRK2) Activity by Extracellular Signal-regulated Kinases
    Julie A. Pitcher, John J. G. Tesmer, Jennifer L. R. Freeman, W. Darrell Capel, W. Carl Stone, Robert J. Lefkowitz · 1999 · Journal of Biological Chemistry
42. Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene
    Arnaldur Hall, Kathrine Damm Meyle, Marina Krarup Lange, Martin Klima, May Sanderhoff, Christina Dahl, Cecilie Abildgaard, Katrine Thorup, Seyed Moein Moghimi, Per Bo Jensen et al. · 2013 · Oncotarget
43. Extracellular Signal–Regulated Kinase Signaling Pathway Regulates Breast Cancer Cell Migration by Maintaining slug Expression
    Haoming Chen, Genfeng Zhu, Yong Li, Ravi N. Padia, Zheng Dong, Zhixing K. Pan, Kebin Liu, Shuang Huang · 2009 · Cancer Research
44. RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer
    Cory Iverson, Gary Larson, Chon Lai, Li‐Tain Yeh, Claudia Dadson, Paul Weingarten, Todd C. Appleby, Todd Vo, Andreas Maderna, Jean‐Michel Vernier et al. · 2009 · Cancer Research
45. A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal
    Federica Catalanotti, Gloria Ximena Reyes, Veronika Jesenberger, Gergana Galabova‐Kovacs, Ricardo De Matos Simoes, Oliviero Carugo, Manuela Baccarini · 2009 · Nature Structural & Molecular Biology
46. A compendium of ERK targets
    Evrim B. Ünal, Florian Uhlitz, Nils Blüthgen · 2017 · FEBS Letters
47. Mek2 Is Dispensable for Mouse Growth and Development
    Louis-François Bélanger, Sophie Roy, Michel G. Tremblay, Barbara K. Brott, Ann‐Muriel Steff, Walid M. Mourad, Patrice Hugo, Raymond Leo Erikson, Jean Charron · 2003 · Molecular and Cellular Biology
48. Development of encorafenib for BRAF-mutated advanced melanoma
    Peter Koelblinger, Thuerigen Olaf, Reinhard Dummer · 2017 · Current Opinion in Oncology
49. ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4
    Myoung Ok Kim, Sung-Hyun Kim, Yong‐Yeon Cho, Janos Nadas, Chul‐Ho Jeong, Ke Yao, Dong Joon Kim, Dong-Hoon Yu, Young-Sam Keum, Kun-Yeong Lee et al. · 2012 · Nature Structural & Molecular Biology
50. Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity
    Ishii, Nobuya, Harada, Naoki, Joseph, Eric W., Ohara, Kazuhiro, Miura, Takaaki, Sakamoto, Hiroshi, Matsuda, Yutaka, Tomii, Yasushi, Tachibana-Kondo, Yukako, Iikura, Hitoshi et al. · 2013 · Cancer Research
51. Ribosomal S6 Kinase (RSK) Regulates Phosphorylation of Filamin A on an Important Regulatory Site
    Michele Sue‐Ann Woo, Yasutaka Ohta, Isaac Rabinovitz, Thomas P. Stossel, John Blenis · 2004 · Molecular and Cellular Biology
52. ERK1/2‐dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl‐1 and Bcl‐xL
    Ewings, Katherine E, Hadfield‐Moorhouse, Kathryn, Wiggins, Ceri M, Wickenden, Julie A, Balmanno, Kathryn, Gilley, Rebecca, Degenhardt, Kurt, White, Eileen, Cook, Simon J · 2007 · The EMBO Journal
53. Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases
    Yasushi Kondo, Jana Ognjenović, Saikat Banerjee, Deepti Karandur, Alan Merk, Kayla R. Kulhanek, Kathryn Wong, Jeroen P. Roose, Sriram Subramaniam, John Kuriyan · 2019 · Science
54. Expression of Endogenous Oncogenic V600EB-raf Induces Proliferation and Developmental Defects in Mice and Transformation of Primary Fibroblasts
    Kathryn Mercer, Susan M. Giblett, Stuart A. Green, David J. Lloyd, Silvy da Rocha Dias, Mark Plumb, Richard Marais, Catrin A. Pritchard · 2005 · Cancer Research
55. Evidence for an epidermal growth factor-stimulated protein kinase cascade in Swiss 3T3 cells. Activation of serine peptide kinase activity by myelin basic protein kinases in vitro.
    Natalie G. Ahn, E G Krebs · 1990 · Journal of Biological Chemistry
56. Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression
    Klaus P. Hoeflich, Sylvia Herter, Janet Tien, Leo Lap-Yan Wong, Leanne Berry, Jocelyn Chan, Carol Lynn O'Brien, Zora D. Modrusan, Somasekar Seshagiri, Mark R. Lackner et al. · 2009 · Cancer Research
57. MEK Is a Key Regulator of Gliogenesis in the Developing Brain
    Xiaoyan Li, Jason M. Newbern, Yaohong Wu, Meghan Morgan-Smith, Jian Zhong, Jean Charron, William D. Snider · 2012 · Neuron
58. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets‐associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
    Dionyssios N. Sgouras, Meropi Athanasiou, Gregory Beal, Robert J. Fisher, D. G. Blair, G J Mavrothalassitis · 1995 · The EMBO Journal
59. ERK-MAPK Drives Lamellipodia Protrusion by Activating the WAVE2 Regulatory Complex
    Mendoza, Michelle C., Er, E. Emrah, Zhang, Wenjuan, Ballif, Bryan A., Elliott, Hunter L., Danuser, Gaudenz, Blenis, John · 2011 · Molecular Cell
60. MEK Guards Proteome Stability and Inhibits Tumor-Suppressive Amyloidogenesis via HSF1
    Zijian Tang, Siyuan Dai, Yishu He, Rosalinda A. Doty, Leonard D. Shultz, Stephen B. Sampson, Chengkai Dai · 2015 · Cell
61. Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells
    Bradley Smith, Xenia Schafer, Aslihan Ambeskovic, Cody M. Spencer, Hartmut Land, Joshua C. Munger · 2016 · Cell Reports
62. Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade
    Jörg Kotzka, Dirk Müller‐Wieland, Gunther Roth, Lorena Kremer, Martina Munck, Sandra Schürmann, Birgit Knebel, Wilhelm Krone · 2000 · Journal of Lipid Research
63. Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors.
    Tsuneo Ikenoue, Yohko Hikiba, Fumihiko Kanai, Yasuo Tanaka, Jun Imamura, Takaaki Imamura, Miki Ohta, Hideaki Ijichi, Keisuke Tateishi, Takayuki Kawakami et al. · 2003 · PubMed
64. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer
    Q Ye, Weikang Cai, Yuanyuan Zheng, Bernard Mark Evers, Qing‐Bai She · 2013 · Oncogene
65. p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells
    Sumin Kang, Shannon Elf, Katherine Lythgoe, Taro Hitosugi, Jack Taunton, Wei Zhou, Li Xiong, Dongsheng Wang, Susan Müller, Songqing Fan et al. · 2010 · Journal of Clinical Investigation
66. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity.
    R H Chen, Peter Juo, Tom Curran, John Blenis · 1996 · PubMed
67. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene
    Catrin A. Pritchard, Laurel M. Bolin, Robyn Maree Slattery, Robert J. S. Murray, Martin McMahon · 1996 · Current Biology
68. Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
    James F. Blake, Michael Burkard, Jocelyn Chan, Huifen Chen, Kang-Jye Chou, Dolores Diaz, Danette A. Dudley, John J. Gaudino, Stephen E. Gould, Jonas A. Grina et al. · 2016 · Journal of Medicinal Chemistry
69. The Extracellular Signal-Regulated Kinase Pathway Phosphorylates AML1, an Acute Myeloid Leukemia Gene Product, and Potentially Regulates Its Transactivation Ability
    Tanaka, Tomoyuki, Kurokawa, Mineo, Ueki, Kohjiro, Tanaka, Kozo, Imai, Yoichi, Mitani, Kinuko, Okazaki, Kenji, Sagata, Noriyuki, Yazaki, Yoshio, Shibata, Yoichi et al. · 1996 · Molecular and Cellular Biology
70. Mutant-selective degradation by BRAF-targeting PROTACs
    Alabi, Shanique, Jaime-Figueroa, Saul, Yao, Zhan, Gao, Yijun, Hines, John, Samarasinghe, Kusal T. G., Vogt, Lea, Rosen, Neal, Crews, Craig M. · 2021 · Nature Communications
71. Activation of Brain B-Raf Protein Kinase by Rap1B Small GTP-binding Protein
    Toshihisa Ohtsuka, Kazuya Shimizu, Bunpei Yamamori, Shinya Kuroda, Yoshimi Takai · 1996 · Journal of Biological Chemistry
72. BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors
    Karisa C. Schreck, Stuart A. Grossman, Christine A. Pratilas · 2019 · Cancers
73. Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer
    Carol Ann Lange, Douglas Yee · 2011 · Endocrine Related Cancer
74. Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy
    Zhe Zhang, Xiaoyun Zhou, Hujia Shen, Dexing Wang, Yanhong Wang · 2009 · BMC Medicine
75. Activation of c‐Raf‐1 by Ras and Src through different mechanisms: activation in vivo and in vitro
    David Stokoe, Frank P. McCormick · 1997 · The EMBO Journal
76. The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf
    Weiquan Li, Min Han, Kun‐Liang Guan · 2000 · Genes & Development
77. Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells
    Juran Kato‐Stankiewicz, Irina Hakimi, Gang Zhi, Jie Zhang, Ilya G. Serebriiskii, Lea Guo, Hironori Edamatsu, Hiroshi Koide, Sanjay Menon, Robert W. Eckl et al. · 2002 · Proceedings of the National Academy of Sciences
78. Mek1/2 MAPK Kinases Are Essential for Mammalian Development, Homeostasis, and Raf-Induced Hyperplasia
    Florence A. Scholl, Phillip A. Dumesic, Deborah I. Barragan, Kazutoshi Harada, Vickram Bissonauth, Jean Charron, Paul A. Khavari · 2007 · Developmental Cell
79. Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties
    Yijun Gao, Matthew T. Chang, Daniel McKay, Na Na, Bing Zhou, Rona D. Yaeger, Neilawattie M. Torres, Keven Muniz, Matthias Drosten, Mariano Barbacid et al. · 2018 · Cancer Discovery
80. Extracellular Signal-Regulated Kinases Phosphorylate Mitogen-Activated Protein Kinase Phosphatase 3/DUSP6 at Serines 159 and 197, Two Sites Critical for Its Proteasomal Degradation
    Sandrine Marchetti, Clotilde Gimond, Jean‐Claude Chambard, Thomas Touboul, Danièle Roux, Jacques Pouysségur, Gilles Pagès · 2005 · Molecular and Cellular Biology
81. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C- raf kinase supports an antisense mechanism of action in vivo
    Brett P. Monia, Henri M. Sasmor, Joseph F. Johnston, Susan M. Freier, Elena A. Lesnik, Marcel Muller, Thomas M. Geiger, Karl‐Heinz Altmann, Heinz E. Moser, Doriano Fabbro · 1996 · Proceedings of the National Academy of Sciences
82. Interactions of β and γENaC with Nedd4 Can Be Facilitated by an ERK-mediated Phosphorylation
    Haikun Shi, Carol Asher, Alexandre Chigaev, Yuval Yung, Eitan Reuveny, Rony Seger, Haim Garty · 2002 · Journal of Biological Chemistry
83. MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms
    Pui-Kei Wu, Jong-In Park · 2015 · Seminars in Oncology
84. Phosphorylation of BRAF by AMPK Impairs BRAF-KSR1 Association and Cell Proliferation
    Che‐Hung Shen, Ping Yuan, Rolando Pérez‐Lorenzo, Yaqing Zhang, Sze Xian Lee, Yang Ou, John M. Asara, Lewis C. Cantley, Bin Zheng · 2013 · Molecular Cell
85. Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
    Camilo E. Quevedo, Abimael Cruz-Migoni, Nicolas Béry, Ami Miller, Tomoyuki U Tanaka, Donna Petch, Carole J. R. Bataille, Lydia Y. W. Lee, Phillip S. Fallon, Hanna Tulmin et al. · 2018 · Nature Communications
86. Transactivation of Fra-1 and Consequent Activation of AP-1 Occur Extracellular Signal-Regulated Kinase Dependently
    Matthew R. Young, Rajalakshmi R. Nair, Natalie R. Bucheimer, Preety Tulsian, Nicole Brown, Cristi Chapp, Tin-Chen Hsu, Nancy H. Colburn · 2002 · Molecular and Cellular Biology
87. Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti‐myeloma activity in vitro and in vivo
    Kihyun Kım, Sun‐Young Kong, Mariateresa Fulciniti, Xianfeng Li, Weihua Song, Sabikun Nahar, Peter Burger, Mathew J. Rumizen, Klaus Podar, Dharminder Chauhan et al. · 2010 · British Journal of Haematology
88. Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin.
    D H Campbell, R L Sutherland, Roger J. Daly · 1999 · PubMed
89. Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer
    Qing Dong, Douglas R. Dougan, Xianchang Gong, Petro Halkowycz, Bohan Jin, Toufike Kanouni, Shawn M. O’Connell, Nicholas Scorah, Lihong Shi, Michael B. Wallace et al. · 2011 · Bioorganic & Medicinal Chemistry Letters
90. Klf2 Is an Essential Factor that Sustains Ground State Pluripotency
    Jia-Chi Yeo, Jianming Jiang, Zi-Ying Tan, Daniel Yim, Jia-Hui Ng, Jonathan Göke, Petra Kraus, Hongqing Liang, Kevin Andrew Uy Gonzales, Han-Chung Chong et al. · 2014 · Cell stem cell
91. Differences and similarities between cancer and somatic stem cells: therapeutic implications
    Fiorella Rossi, Hunter Noren, Richard Jove, Vladimir Beljanski, Karl‐Henrik Grinnemo · 2020 · Stem Cell Research & Therapy
92. Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma
    Marcin B. Imielinski, Heidi E. Greulich, Bethany Kaplan, Luiz Henrique Araujo, Joseph M. Amann, Leora Horn, Joan H. Schiller, Miguel Angel Villalona-Calero, Matthew M. Meyerson, David Paul Carbone · 2014 · Journal of Clinical Investigation
93. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1
    Ki Won Lee, Nam Jun Kang, Evgeny A. Rogozin, H.-G. Kim, Yong‐Yeon Cho, Ann M. Bode, H. J. Lee, Young‐Joon Surh, G. Tim Bowden, Z. Dong · 2007 · Carcinogenesis
94. ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewal
    Sung-Hyun Kim, Myoung Ok Kim, Yong‐Yeon Cho, Ke Yao, Dong Joon Kim, Chul‐Ho Jeong, Dong Hoon Yu, Ki Beom Bae, Eun Jin Cho, Sung Keun Jung et al. · 2014 · Stem Cell Research
95. Resistance to MEK inhibitors: should we co-target upstream?
    Poulikakos, Poulikos I., Solit, David B. · 2011 · Science Signaling
96. Insulin-activated Erk-mitogen-activated Protein Kinases Phosphorylate Sterol Regulatory Element-binding Protein-2 at Serine Residues 432 and 455 in Vivo
    Jörg Kotzka, Stefan Lehr, Gunther Roth, Haluk Avci, Birgit Knebel, Dirk Müller‐Wieland · 2004 · Journal of Biological Chemistry
97. Raf-1 Physically Interacts with Rb and Regulates Its Function: a Link between Mitogenic Signaling and Cell Cycle Regulation
    Sheng Wang, Richik N. Ghosh, Srikumar Chellappan · 1998 · Molecular and Cellular Biology
98. Phosphorylation of Raf-1 by p21-activated Kinase 1 and Src Regulates Raf-1 Autoinhibition
    Nancy H. Tran, Jeffrey A. Frost · 2003 · Journal of Biological Chemistry
99. Activity of Plasma Membrane-recruited Raf-1 Is Regulated by Ras via the Raf Zinc Finger
    Sandrine Roy, Annette Lane, Jun Yan, Robert McPherson, John F. Hancock · 1997 · Journal of Biological Chemistry
100. Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf
     Tilman Brummer, Heike Naegele, Michael G. Reth, Yukiko Misawa · 2003 · Oncogene
101. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer
     Paola A. Bignone, K Y Lee, Y Liu, Gracy Emilion, J Finch, Ashley Edward Roy Soosay, F. Mark L. Charnock, Stephan Beck, Ian Dunham, Andrew J. J. Mungall et al. · 2006 · Oncogene
102. Phosphorylation by CK2 and MAPK enhances calnexin association with ribosomes
     Éric Chevet, Hetty N. Wong, D. Gerber, Claude Cochet, A. Fazel, P.H. Cameron, Jennifer N. Gushue, David Y. Thomas, John J.M. Bergeron · 1999 · The EMBO Journal
103. The mitogen‐activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB
     Zoë A. Felton-Edkins, Jennifer A. Fairley, Emma L. Graham, Imogen M. Johnston, Robert J. White, Pamela H. Scott · 2003 · The EMBO Journal
104. Resorcylic Acid Lactones. Naturally Occurring Potent and Sclective Inbibitors.
     Annie Zhao, Seok H. Lee, MARINA MOIENA, Rosalind G. Jenkins, Denis R. Patrick, Hans E. Huber, MICHAEL A. GOETZ, Otto D. Hensens, Deborah L. Zink, Dolores Vilella et al. · 1999 · The Journal of Antibiotics
105. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a.
     T. Pircher, H. Petersen, Jan-Åke Gustafsson, L. Haldosen · 1999 · Molecular Endocrinology
106. Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives
     Masanori Okaniwa, Masaaki Hirose, Takeo Arita, Masato Yabuki, Akito Nakamura, Terufumi Takagi, Tomohiro Kawamoto, Noriko Uchiyama, Akihiko Sumita, Shunichirou Tsutsumi et al. · 2013 · Journal of Medicinal Chemistry
107. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling
     Xin Li, Yao‐Kuang Huang, Jing Jiang, Stuart J. Frank · 2008 · Cellular Signalling
108. Isoform-Specific Ras Functions in Development and Cancer
     Margaret P. Quinlan, Jeffrey E. Settleman · 2009 · Future Oncology
109. Erk Signaling Suppresses Embryonic Stem Cell Self-Renewal to Specify Endoderm
     William Baskerville Hamilton, Joshua M. Brickman · 2014 · Cell Reports
110. Phosphorylation of Nuclear Phospholipase C β1 by Extracellular Signal-Regulated Kinase Mediates the Mitogenic Action of Insulin-Like Growth Factor I
     Aimin Xu, Pann‐Ghill Suh, Nelly Marmy-Conus, Richard B. Pearson, Yong‐Seok Oh, Lucio Cocco, R. S. Gilmour · 2001 · Molecular and Cellular Biology
111. Therapeutic targeting of RAS: New hope for drugging the “undruggable”
     Imran Khan, Joshua Matthew Rhett, John P. O’Bryan · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
112. Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons
     Stefan Wiese, Geng Pei, Christoph Karch, Jakob Troppmair, Bettina Holtmann, Ulf Rüdiger Rapp, Michael Sendtner · 2001 · Nature Neuroscience
113. IEX‐1: a new ERK substrate involved in both ERK survival activity and ERK activation
     Josefina Garcia, Yunbin Ye, Valérie Arranz, Claire Letourneux, Guillaume Pézeron, Françoise Porteu · 2002 · The EMBO Journal
114. MAPKAPK5, a Novel Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase, Is a Substrate of the Extracellular-Regulated Kinase (ERK) and p38 Kinase
     Hong Ni, Xuhong Sunny Wang, Katrina Diener, Zhengbin Yao · 1998 · Biochemical and Biophysical Research Communications
115. A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas
     Yu Sun, John A. Alberta, Catherine Pilarz, David Calligaris, Emily J. Chadwick, Shakti H Ramkissoon, Lori A. Ramkissoon, Verónica Matía, Emanuele Mazzola, Liliana Christova Goumnerova et al. · 2016 · Neuro-Oncology
116. Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
     Eva Chung, Motonari Kondo · 2010 · Immunologic Research
117. Transcriptional Repressor ERF Is a Ras/Mitogen-Activated Protein Kinase Target That Regulates Cellular Proliferation
     Lionel Le Gallic, Dionyssios N. Sgouras, Gregory Beal, George Mavrothalassitis · 1999 · Molecular and Cellular Biology
118. ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer
     Kai Li, Jian‐Lin Wu, Baifu Qin, Zong-Min Fan, Qin Tang, Weisi Lu, Haipeng Zhang, Fan Xing, Manqi Meng, Shaomin Zou et al. · 2019 · Cell Research
119. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells
     Bin You, Yi‐Lin Yang, Zhidong Xu, Yuyuan Dai, Shu Liu, Jian‐Hua Mao, Osamu Tetsu, Hui Li, David M. Jablons, Liang You · 2015 · Oncotarget
120. Bombesin, Lysophosphatidic Acid, and Epidermal Growth Factor Rapidly Stimulate Focal Adhesion Kinase Phosphorylation at Ser-910
     Isabel Hunger‐Glaser, Eduardo Pérez Salazar, James W. Sinnett‐Smith, Enrique Rozengurt · 2003 · Journal of Biological Chemistry
121. RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
     Ting Jin, Hugo Lavoie, Malha Sahmi, Maud David, Christine Hilt, Amy Hammell, Marc Therrien · 2017 · Nature Communications
122. ERKs and p38 Kinases Mediate Ultraviolet B-induced Phosphorylation of Histone H3 at Serine 10
     Shu-Ping Zhong, Weiya Ma, Zigang Dong · 2000 · Journal of Biological Chemistry
123. A Novel RAF Kinase Inhibitor with DFG-Out–Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation
     Irene C. Waizenegger, Anke Baum, Steffen Steurer, Heinz Stadtmüller, Gerd Bader, Otmar Schaaf, Pilar Garin‐Chesa, Andreas Schlattl, Norbert Schweifer, Christian Haslinger et al. · 2016 · Molecular Cancer Therapeutics
124. ERK and RhoA Differentially Regulate Pseudopodia Growth and Retraction during Chemotaxis
     Anar A. Brahmbhatt, Richard L. Klemke · 2003 · Journal of Biological Chemistry
125. c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation
     Gretchen Poortinga, Meaghan Wall, Elaine Sanij, Kasia Siwicki, Jason Ellul, Daniel V. Brown, Timothy P. Holloway, Ross D. Hannan, Grant A. McArthur · 2010 · Nucleic Acids Research
126. Oncogenic BRAF Alterations and Their Role in Brain Tumors
     Felix Behling, Jens Schittenhelm · 2019 · Cancers
127. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling
     Neil S. Dhawan, Alex P. Scopton, Arvin C. Dar · 2016 · Nature
128. The c‐Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK‐ERK and Akt‐independent mechanism
     Paul C. Chin, Li Liu, Brad E. Morrison, Ambreena Siddiq, Rajiv R. Ratan, Teodoro Bottiglieri, Santosh R. D’Mello · 2004 · Journal of Neurochemistry
129. Genetic Demonstration of a Redundant Role of Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Mitogen-Activated Protein Kinases in Promoting Fibroblast Proliferation
     Laure Voisin, Marc K. Saba-El-Leil, Catherine Julien, Christophe Frémin, Sylvain Meloche · 2010 · Molecular and Cellular Biology
130. Phosphorylation of Ser-42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck.
     David G. Winkler, I Park, T Kim, N S Payne, Christopher T. Walsh, Jack L. Strominger, J Shin · 1993 · Proceedings of the National Academy of Sciences
131. Convergence of Cell Cycle Regulation and Growth Factor Signals on GRASP65
     Shin‐ichiro Yoshimura, Katsuji Yoshioka, Francis A. Barr, Martin Lowe, Kazuhisa Nakayama, Shoji Ohkuma, Nobuhiro Nakamura · 2005 · Journal of Biological Chemistry
132. Direct inhibition of RAS: Quest for the Holy Grail?
     Russell Spencer-Smith, John P. O’Bryan · 2017 · Seminars in Cancer Biology
133. K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling
     Qing Yin, Tao Han, Bin Fang, Guolin Zhang, Chao Zhang, Evan R. Roberts, Victoria Izumi, Mengmeng Zheng, Shulong Jiang, Xiu Yin et al. · 2019 · Nature Communications
134. Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells
     James R. Henry, Michael D. Kaufman, Sheng-Bin Peng, Yu Mi Ahn, Timothy M. Caldwell, Lakshminarayana Vogeti, Hanumaiah Telikepalli, Wei-Ping Lu, Molly M. Hood, Thomas J. Rutkoski et al. · 2015 · Journal of Medicinal Chemistry
135. Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death
     Pei-Yen Yeh, Shuang‐En Chuang, Kun‐Huei Yeh, Ying Song, Lucia Ling-Yuan Chang, Ann‐Lii Cheng · 2004 · Oncogene
136. Structural Determinants of Ras-Raf Interaction Analyzed in Live Cells
     Tzvetanka Bondeva, András Balla, Péter Várnai, Tamás Balla · 2002 · Molecular Biology of the Cell
137. A PP2A regulatory subunit positively regulates Ras-mediated signaling during Caenorhabditis elegans vulval induction
     Derek Sieburth, Meera V. Sundaram, R. M. Howard, M. Han · 1999 · Genes & Development
138. Role of a cysteine residue in the active site of ERK and the MAPKK family
     Makoto Ohori, Takayoshi Kinoshita, Seiji Yoshimura, Masaichi Warizaya, Hidenori Nakajima, Hiroshi Miyake · 2006 · Biochemical and Biophysical Research Communications
139. Small‐Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics
     Jeremy L. Yap, Shilpa A. Worlikar, Alexander D. MacKerell, Paul Shapiro, Steven Fletcher · 2010 · ChemMedChem
140. Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)
     Richard A. Ward, Mark J. Anderton, Paul A. Bethel, Jason Breed, Calum Cook, Emma Jane Davies, Andrew P. Dobson, Zhiqiang Dong, Gary Fairley, Paul M. Farrington et al. · 2019 · Journal of Medicinal Chemistry
141. Inducible activation of Ras and Raf in adult epidermis.
     Masahito Tarutani, Ti Cai, Maya Dajee, Paul A. Khavari · 2003 · PubMed
142. The Strength of Interaction at the Raf Cysteine-Rich Domain Is a Critical Determinant of Response of Raf to Ras Family Small GTPases
     Tomoyo Okada, Chang‐Deng Hu, Taiguang Jimmy Jin, Ken‐ichi Kariya, Yuriko Yamawaki‐Kataoka, Tohru Kataoka · 1999 · Molecular and Cellular Biology
143. MCRIP1, an ERK Substrate, Mediates ERK-Induced Gene Silencing during Epithelial-Mesenchymal Transition by Regulating the Co-Repressor CtBP
     Kenji Ichikawa, Yuji Kubota, Takanori Nakamura, Jane S. Weng, Taichiro Tomida, Haruo Saito, Mutsuhiro Takekawa · 2015 · Molecular Cell
144. Requirement forMap2k1(Mek1) in extra-embryonic ectoderm during placentogenesis
     Vickram Bissonauth, Sophie Roy, Mathieu Gravel, Stéphanie Guillemette, Jean Charron · 2006 · Development
145. Selective Raf inhibition in cancer therapy
     Vladimir Khazak, Igor A. Astsaturov, Ilya G. Serebriiskii, Erica A. Golemis · 2007 · Expert Opinion on Therapeutic Targets
146. Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent
     Yoshiaki Isshiki, Yasunori Kohchi, Hitoshi Iikura, Yasuaki Matsubara, Kohsuke Asoh, Takeshi Murata, Masami Kohchi, Eisaku Mizuguchi, Shinji Tsujii, Kazuo Hattori et al. · 2011 · Bioorganic & Medicinal Chemistry Letters
147. BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF -Mutated Colorectal Cancers
     Zhiyu Tang, Xi Yuan, Rong Du, Shing-Hu Cheung, Guoliang Zhang, Jing Wei, Yuan Zhao, Yingcai Feng, Hao Peng, Yi Zhang et al. · 2015 · Molecular Cancer Therapeutics
148. Crucial requirement of ERK/MAPK signaling in respiratory tract development
     Olivier Boucherat, Valérie Nadeau, Félix‐Antoine Bérubé‐Simard, Jean Charron, Lucie Jeannotte · 2014 · Development
149. Phosphorylation acts positively and negatively to regulate MRTF-A subcellular localisation and activity
     Panayiotou, Richard, Miralles, Francesc, Pawlowski, Rafal, Diring, Jessica, Flynn, Helen R, Skehel, Mark, Treisman, Richard · 2016 · eLife
150. Phosphorylation of β-arrestin2 at Thr383 by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs
     Elisabeth Cassier, Nathalie Gallay, Thomas Bourquard, Sylvie Claeysen, Joël Bockaert, Pascale Crépieux, Anne Poupon B, Éric Reiter, Philippe Marin, Franck Vandermoere · 2017 · eLife
151. Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.
     Jiin‐Tsuey Cheng, Melanie H. Cobb, Richard J. Baer · 1993 · Molecular and Cellular Biology
152. Identification of the Anti-proliferative Protein Tob as a MAPK Substrate
     Momoko Maekawa, Eisuke Nishida, Takuji Tanoue · 2002 · Journal of Biological Chemistry
153. Different Effects of Point Mutations within the B-Raf Glycine-Rich Loop in Colorectal Tumors on Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase and Nuclear Factor κB Pathway and Cellular Transformation
     Tsuneo Ikenoue, Yohko Hikiba, Fumihiko Kanai, Jun Aragaki, Yasuo Tanaka, Jun Imamura, Takaaki Imamura, Miki Ohta, Hideaki Ijichi, Keisuke Tateishi et al. · 2004 · Cancer Research
154. cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating Ser-43 of Raf-1 in the MAPK/ERK pathway
     Charlotte Ramstad, Vibeke Sundvold, Heidi K. Johansen, Tor Lea · 2000 · Cellular Signalling
155. Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF -mutant lung cancer
     Ross A. Okimoto, Luping Lin, Victor R. Olivas, Elton Chan, Evan Markegard, Andrey Rymar, Dana S. Neel, Xiao Chen, Golzar Hemmati, Gideon E. Bollag et al. · 2016 · Proceedings of the National Academy of Sciences
156. Diminished WNT → β-catenin → c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors
     Joseph M. Juan, Teruyuki Muraguchi, Gioia Iezza, Rosalie C. Sears, Martin McMahon · 2014 · Genes & Development
157. ERK Phosphorylates p66shcA on Ser36 and Subsequently Regulates p27kip1Expression via the Akt-FOXO3a Pathway: Implication of p27kip1in Cell Response to Oxidative Stress
     Yuanyu Hu, Xueying Wang, Li Zeng, Deyu Tarika Cai, Kanaga Sabapathy, Stephen P. Goff, Eduardo J. Firpo, Baojie Li · 2005 · Molecular Biology of the Cell
158. Identification of a Novel Mitogen-Activated Protein Kinase Kinase Activation Domain Recognized by the Inhibitor PD 184352
     Amy M. Delaney, John A. Printen, Huifen Chen, Eric B. Fauman, David T. Dudley · 2002 · Molecular and Cellular Biology
159. ERK1-Deficient Mice Show Normal T Cell Effector Function and Are Highly Susceptible to Experimental Autoimmune Encephalomyelitis
     Tanya Nekrasova, Carey L. Shive, Yuehua Gao, Kazuyuki Kawamura, Rocio Guardia, Gary E. Landreth, Thomas G. Forsthuber · 2005 · The Journal of Immunology
160. Activation of the Hexosamine Pathway Leads to Phosphorylation of Insulin Receptor Substrate-1 on Ser307 and Ser612 and Impairs the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Insulin Biosynthetic Pathway in RIN Pancreatic β-Cells
     Francesco Andreozzi, Cristina D’Alessandris, Massimo Federici, Emanuela Laratta, Silvia Del Guerra, Stefano Del Prato, Piero Marchetti, Renato Lauro, Francesco Perticone, Giorgio Sesti · 2004 · Endocrinology
161. ERF Nuclear Shuttling, a Continuous Monitor of Erk Activity That Links It to Cell Cycle Progression
     Lionel Le Gallic, Laura Virgilio, Philip Cohen, Benoît Biteau, George Mavrothalassitis · 2004 · Molecular and Cellular Biology
162. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function
     Lixin Wan, Ming Chen, Juxiang Cao, Xiangpeng Dai, Qing Yin, Jinfang Zhang, Su-Jung Song, Ying Lu, Jing Liu, Hiroyuki Inuzuka et al. · 2017 · Cancer Discovery
163. CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles
     Payal Jain, Tamara M. Fierst, Harry J. Han, Tiffany Lee Smith, Aesha Vakil, Phillip B. Storm, Adam Cain Resnick, Angela Jae Waanders · 2017 · Oncogene
164. The MAP kinase cascade. Discovery of a new signal transduction pathway
     Natalie G. Ahn · 1993 · Molecular and Cellular Biochemistry
165. Selective RAF inhibitor impairs ERK 1/2 phosphorylation and growth in mutant NRAS , vemurafenib‐resistant melanoma cells
     Kaitlyn Le, Erik Scott Blomain, Ulrich Rodeck, Andrew E. Aplin · 2013 · Pigment Cell & Melanoma Research
166. ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy
     Bijay Shankar Jaiswal, Steffen Durinck, Eric W. Stawiski, Jianping Yin, Weiru Wang, Eva Lin, John G. Moffat, Scott E. Martin, Zora D. Modrusan, Somasekar Seshagiri · 2018 · Clinical Cancer Research
167. Phosphorylation of WAVE2 by MAP kinases regulates persistent cell migration and polarity
     Danson, Christopher M., Pocha, Shirin M., Bloomberg, Graham B., Cory, Giles O. · 2007 · Journal of Cell Science
168. Functional analysis of CNK in RAS signaling
     Marc Therrien, Allan M. Wong, Elaine Kwan, Gerald M. Rubin · 1999 · Proceedings of the National Academy of Sciences
169. Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-β-induced nuclear accumulation
     Bernard A.J. Roelen, Ori S. Cohen, Malay K. Raychowdhury, Deborah N. Chadee, Ying E. Zhang, John M. Kyriakis, Alessandro Alessandrini, Herbert Yih-Fuu Lin · 2003 · American Journal of Physiology-Cell Physiology
170. The intermediate-activityL597VBRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway
     Catherine Andreadi, Lai-Kay Maggie Cheung, Susan M. Giblett, Bipin PATEL, Hong Jin, Kathryn Mercer, Tamihiro Kamata, Pearl Lee, Alexander G. Williams, Martin McMahon et al. · 2012 · Genes & Development
171. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway
     Cheol‐Jung Lee, Mee‐Hyun Lee, Sun-Mi Yoo, Kyung-Il Choi, Ji-Hong Song, Jeong‐Hoon Jang, Sei‐Ryang Oh, Hyung Won Ryu, Hye-Suk Lee, Young‐Joon Surh et al. · 2015 · BMC Cancer
172. The RAF-MEK-ERK Pathway: Targeting ERK to Overcome Obstacles of Effective Cancer Therapy
     Zutao Yu, Shiqi Ye, Gaoyun Hu, Meng Lv, Zhijun Tu, Kun Zhou, Qianbin Li · 2015 · Future Medicinal Chemistry
173. Adhesion Stimulates Direct PAK1/ERK2 Association and Leads to ERK-dependent PAK1 Thr212 Phosphorylation
     Liisa J. Sundberg-Smith, Jason T. Doherty, Christopher P. Mack, Joan M. Taylor · 2004 · Journal of Biological Chemistry
174. Protective Role of Raf-1 in Salmonella-Induced Macrophage Apoptosis
     Veronika Jesenberger, Katarzyna J. Procyk, Jochen Rüth, Martin Schreiber, Hans‐Christian Theussl, Erwin Friedrich Wagner, Manuela Baccarini · 2001 · The Journal of Experimental Medicine
175. Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
     Seungmin Shin, Ji‐Sun Kim, Seong-Wook Park, Sei-Yong Jun, Hye-Jin Kweon, Dong-Ki Choi, Dakeun Lee, Yong Beom Cho, Yong‐Sung Kim · 2020 · Science Advances
176. RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma
     Thibault Houlès, Simon‐Pierre Gravel, Geneviève Lavoie, Sejeong Shin, Mathilde Savall, Antoine Méant, Benoı̂t Grondin, Louis Arthur Gaboury, Sang-Oh Yoon, Julie St‐Pierre et al. · 2018 · Cancer Research
177. Identification of Major ERK-Related Phosphorylation Sites in Gab1
     Stefan Lehr, Jörg Kotzka, Haluk Avci, Albert Sickmann, Helmut E. Meyer, Armin Herkner, Dirk Müller‐Wieland · 2004 · Biochemistry
178. Phosphorylation of WAVE Downstream of Mitogen-activated Protein Kinase Signaling
     Hiroaki Miki, Makoto Fukuda, Eisuke Nishida, Tadaomi Takenawa · 1999 · Journal of Biological Chemistry
179. Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome.
     Prafulla C. Gokhale, Chuanbo Zhang, Joseph T. Newsome, Jin Pei, Imran Nazir Ahmad, Aquilur Rahman, Anatoly Dritschilo, Usha N. Kasid · 2002 · PubMed
180. Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function
     Wen Li, Ashley N. Reeb, Binyan Lin, Praveen Subramanian, Erin E. Fey, Catherine R. Knoverek, Rachel L. French, Eileen H. Bigio, Yuna M. Ayala · 2017 · Journal of Biological Chemistry
181. Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)
     Seungwoo Hong, Dong‐Hoon Jin, Jae-Sik Shin, Jai-Hee Moon, Young-Soon Na, Kyung‐Ah Jung, Seung-Mi Kim, Jin Cheon Kim, Kyu‐pyo Kim, Yong Sang Hong et al. · 2012 · Journal of Biological Chemistry
182. Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo.
     Sumayah Jamal, Edward Benjamin Ziff · 1995 · PubMed
183. The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy
     Davide Bedognetti, Jessica P Roelands, Julie V. Decock, Ena Wang, Wouter Hendrickx · 2017 · Emerging Topics in Life Sciences
184. Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik
     Jonathan Lopez, Cédric Hesling, Julien Prudent, Nikolay Popgeorgiev, Rudy Gadet, Ivan Mikaélian, Ruth Rimokh, Germain Gillet, Philippe Gonzalo · 2012 · Cell Death and Differentiation
185. Phosphorylation of Tumor Necrosis Factor Receptor CD120a (p55) by p42 Induces Changes in Its Subcellular Localization
     Vincent Cottin, Annemie Van Linden, David W. H. Riches · 1999 · Journal of Biological Chemistry
186. Recruitment of the Extracellular Signal-Regulated Kinase/Ribosomal S6 Kinase Signaling Pathway to the NFATc4 Transcription Activation Complex
     Teddy Tat Chi Yang, Qiufang Xiong, Isabella A. Graef, Gerald R. Crabtree, Chi-Wing Chow · 2005 · Molecular and Cellular Biology
187. Quantification of spatiotemporal patterns of Ras isoform expression during development
     Anna U. Newlaczyl, Judy M. Coulson, Ian A. Prior · 2017 · Scientific Reports
188. KLF4 Nuclear Export Requires ERK Activation and Initiates Exit from Naive Pluripotency
     Navroop K. Dhaliwal, Kamelia Miri, Scott Davidson, Hala Tamim El Jarkass, Jennifer A. Mitchell · 2018 · Stem Cell Reports
189. Nuclear Receptor and Apoptosis Initiator NGFI-B Is a Substrate for Kinase ERK2
     Hege Holte Slagsvold, Anne-Carine Østvold, Åsa B. Fallgren, Ragnhild E. Paulsen · 2002 · Biochemical and Biophysical Research Communications
190. Extracellular Signal-Regulated Kinase Binds to TFII-I and Regulates Its Activation of the c-fosPromoter
     Dae Won Kim, Brent Cochran · 2000 · Molecular and Cellular Biology
191. E6201 [(3S,4R,5Z,8S,9S,11E)-14-(Ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a Novel Kinase Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase (MEK)-1 and MEK Kinase-1: In Vitro Characterization of Its Anti-Inflammatory and Antihyperproliferative Activities
     Masaki Goto, Jesse C. Chow, Kenzo Muramoto, Kenichi Chiba, Satoshi Yamamoto, Masanori Fujita, Hiroshi Obaishi, Kenji Tai, Yoshiharu Mizui, Isao Tanaka et al. · 2009 · Journal of Pharmacology and Experimental Therapeutics
192. ERK-Induced Activation of TCF Family of SRF Cofactors Initiates a Chromatin Modification Cascade Associated with Transcription
     Cyril Esnault, Francesco Gualdrini, Stuart D. Horswell, Gavin P. Kelly, Aengus Stewart, Philip East, Nik Matthews, Richard Treisman · 2017 · Molecular Cell
193. Phosphorylation of Grb2-Associated Binder 2 on Serine 623 by ERK MAPK Regulates Its Association with the Phosphatase SHP-2 and Decreases STAT5 Activation
     Mary Arnaud‐Arnould, Catherine Crouin, Catherine Déon, Denis Loyaux, Jacques H. Bertoglio · 2004 · The Journal of Immunology
194. Phosphorylation of Serine 43 Is Not Required for Inhibition of c-Raf Kinase by the cAMP-dependent Protein Kinase
     Matthew F. Sidovar, Piotr Kozlowski, Sang Eun Lee, Matthew A. Collins, Yaqin He, Lee M. Graves · 2000 · Journal of Biological Chemistry
195. Phosphorylation of Serine 147 of tis21/BTG2/pc3 by p-Erk1/2 Induces Pin-1 Binding in Cytoplasm and Cell Death
     Jong Wook Hong, Min Sook Ryu, In Kyoung Lim · 2005 · Journal of Biological Chemistry
196. NANOG Is Multiply Phosphorylated and Directly Modified by ERK2 and CDK1 In Vitro
     Justin Brumbaugh, Jason D. Russell, Pengzhi Yu, Michael S. Westphall, Joshua J. Coon, James Alexander Thomson · 2014 · Stem Cell Reports
197. MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
     Sobhana Babu Boga, Yongqi Deng, Liang Wei Zhu, Nan Yang, Alan B Cooper, Gerald W. Shipps, Ronald J. Doll, Neng‐Yang Shih, Hugh Y. H. Zhu, Robert Sun et al. · 2018 · ACS Medicinal Chemistry Letters
198. Corynoxeine Isolated from the Hook of Uncaria rhynchophylla Inhibits Rat Aortic Vascular Smooth Muscle Cell Proliferation through the Blocking of Extracellular Signal Regulated Kinase 1/2 Phosphorylation
     Tack‐Joong Kim, Ju‐Hyun Lee, Jung‐Jin Lee, Ji-Yeon Yu, Bang-Yeon Hwang, Sang‐Kyu Ye, Shujuan Li, Gao Li, Myoung‐Yun Pyo, Yeo‐Pyo Yun · 2008 · Biological and Pharmaceutical Bulletin
199. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
     William P. Schiemann, Lee M. Graves, Heinz Baumann, Karen K. Morella, David P. Gearing, M D Nielsen, Edwin G. Krebs, Neil M. Nathanson · 1995 · Proceedings of the National Academy of Sciences
200. B-Raf autoinhibition in the presence and absence of 14-3-3
     Mingzhen Zhang, Hyunbum Jang, Zhigang Li, David B. Sacks, Ruth Nussinov · 2021 · Structure